Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tetanus toxin, also known as tetanospasmin or TeNT, is a potent neurotoxin produced by the bacterium *Clostridium tetani*. The inactivated form of this toxin, called tetanus toxoid (TT), is widely used as a protein carrier in conjugate vaccines and as an immunogen in the prevention of tetanus. TT provides strong T cell epitopes and enables polysaccharide antigens to induce robust immune responses, especially in infants. In its active form, TeNT binds to neuronal membranes and blocks neurotransmitter release. TT is detoxified to produce non-toxic but highly immunogenic TT for use as a carrier. Recombinant forms and fragments are also being explored to improve safety and manufacturability.
As a toxin: Cleaves synaptobrevin/VAMP, blocking neurotransmitter release. As a toxoid/carrier: Induces T-cell mediated immune response against conjugated antigens.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tetanus Toxin Protein Carrier (Tetanus Toxoid) (TT).